This compound is a pharmaceutical impurity reference standard, specifically a pyrazinoyl derivative of phenylalanine. It is characterized by the presence of both an amide and a carboxylic acid functional group, along with aromatic and heterocyclic ring systems.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing N-(pyrazine-2-yl-carbonyl)-L-phenylalanine?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N-[(2R)-2-Hydroxy-2-(3-hydroxyphenyl)ethyl]-N-methyl-glycine
pharmaceutical intermediate
N-Fmoc-N'-trityl-L-histidine
pharmaceutical intermediate
(R)-(-)-N-Boc-3-pyrrolidinol
pharmaceutical intermediate
Methyl 5-(chlorosulfonyl)-2-fluorobenzoate
pharmaceutical intermediate
N-(2-Pyrazinylcarbonyl)-L-phenylalanine
pharmaceutical intermediate
N-[(1R)-1-Borono-3-methylbutyl]-Nalpha-(pyrazine-2-carbonyl)-D-phenylalaninamide
pharmaceutical raw material
Bortezomib
pharmaceutical raw material
5-methyl-N-(2-(4-sulfamoylphenyl)ethyl)pyrazine-2-carboxamide
pharmaceutical intermediate
3-phenyl-2-(pyrazine-2-carbonylamino)propanoic acid
DWYZPDHMMZGQAP-UHFFFAOYSA-N
C1=CC=C(C=C1)CC(C(=O)O)NC(=O)C2=NC=CN=C2
—
Sourcing N-(pyrazine-2-yl-carbonyl)-L-phenylalanine?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.